Skip to main content
. 2024 Apr 29;47(7):1152–1161. doi: 10.2337/dc23-2003

Table 3.

Association between HbA1c and glycemic control (independently) and prevalent MCI (average 7 years from visit 1; laboratory measurement of HbA1c) in SOL-INCA

MCI, OR [95% CI]
M1 M2 M3 M4 M5
HbA1c (%) 1.23*** [1.15; 1.32] 1.22*** [1.14; 1.31] 1.21*** [1.13; 1.30] 1.20*** [1.12; 1.29] 1.20*** [1.11; 1.29]
Glycemic control (HbA1c)
 No diabetes Ref. Ref. Ref. Ref. Ref.
 Prediabetes 0.96 [0.69; 1.34] 0.93 [0.67; 1.29] 0.93 [0.67; 1.28] 0.93 [0.67; 1.28] 0.90 [0.64; 1.25]
 Controlled 1.10 [0.69; 1.77] 1.05 [0.66; 1.69] 1.04 [0.65; 1.67] 1.02 [0.64; 1.65] 0.99 [0.61; 1.60]
 Poorly controlled 2.37*** [1.72; 3.26] 2.22*** [1.62; 3.05] 2.14*** [1.56; 2.95] 2.06*** [1.50; 2.84] 1.99*** [1.44; 2.75]
 Unweighted n 5,747 5,747 5,747 5,747 5,747

M1 adjusts for age, sex; M2 adds education; M3 adds additional adjustment for Hispanic/Latino heritage and study site (center); M4 adds depressive symptoms; M5 adds diet, physical activity, BMI, alcohol consumption, and smoking. For the categorical measure, the no diabetes group is the reference (Ref.) in the models used to calculate the marginal estimates.

***

P < 0.001.